Clinical trial

INHERIT EGFR - Studying Germline EGFR Mutations

NCT01754025

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2012-12-28

PhaseN/A

Study timeline

Study start (actual)2012-12-28Date precision: day

Registry last updated2025-11-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

Sponsors & collaborators

Dana-Farber Cancer Institutelead sponsor

Addario Lung Cancer Medical Institutecollaborator

Mapped research locations

BostonMassachusetts, United States1 NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01754025 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.